Adderall XR and Cognitive Impairment in MS

Clinical trial NCT02676739 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02676739
Sponsor: Sarah Morrow
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2016-05-20
Primary completion: 2024-11-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.